Synthesis, Physicochemical and Anticonvulsant Properties of New N‐(Pyridine‐2‐yl) Derivatives of 2‐Azaspiro[4.4]nonane and [4.5]decane‐1,3‐dione. Part II
- 28 April 2006
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 339 (5), 255-261
- https://doi.org/10.1002/ardp.200500219
Abstract
A series of N-(pyridine-2-yl) derivatives of 2-azaspiro[4.4]nonane- (1a–e), 2-azaspiro[4.5]decane- (2a–e) and 6-methyl-2-azaspiro[4.5]decane-1,3-dione (3a–e) were synthesized and tested for their anticonvulsant activity in the maximum electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) seizure threshold tests. To explain the possible mechanism of action, the most active compounds N-(3-methylpyridine-2-yl)-2-azaspiro[4.4]nonane-1,3-dione (1b), N-(3-methylpyridine-2-yl)-2-azaspiro[4.5]decane-1,3-dione (2b), N-(4-methylpyridine-2-yl)-2-azaspiro[4.5]decane-1,3-dione (2c), and N-(3-methylpyridine-2-yl)-6-methyl-2-azaspiro[4.5]decane-1,3-dione (3b) were tested in vitro for their influence on voltage-sensitive calcium channel receptors, however, they revealed low affinities. For all synthesized compounds the lipophilicity was determined by use of RP-TLC method. The correlation between the lipophilicity and anticonvulsant activity was obtained – the higher the lipophilicity the stronger the anticonvulsant efficacy.Keywords
This publication has 21 references indexed in Scilit:
- Synthesis, physicochemical and anticonvulsant properties of N-benzyl and N-aminophenyl derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione. Part IIl Farmaco, 2005
- Relationships between the lipophilicity and anticonvulsant activity of N-benzyl-2-azaspiro[4.4]nonane- and [4.5]decane-1,3-dione derivativesJournal of Planar Chromatography – Modern TLC, 2005
- Quantitative structure—retention and retention—activity relationships of some 1,3-oxazolidine systems by RP-HPTLC and PCAJournal of Pharmaceutical and Biomedical Analysis, 2004
- Synthesis and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)-methyl] derivatives of 3-aryl pyrrolidine-2,5-dione and 2-aza-spiro[4.4]nonane-1,3-dioneIl Farmaco, 2003
- Block of T -Type Ca2+ Channels Is an Important Action of Succinimide Antiabsence DrugsEpilepsy Currents, 2002
- Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model epilepsiesEuropean Neuropsychopharmacology, 1992
- Synthetic Approach to the B-Ring of the Peptide Antibiotic NisinJournal of Pharmacy and Pharmacology, 1990
- Spirosuccinimides as Potential AnticonvulsantsJournal of Pharmaceutical Sciences, 1985
- Spiro[4.5] and spiro[4.6] carboxylic acids: cyclic analogs of valproic acid synthesis and anticonvulsant evaluationJournal of Medicinal Chemistry, 1985
- Antiepileptic Drug Development: II. Anticonvulsant Drug ScreeningEpilepsia, 1978